RegenxBio Patents – Insights & Stats

RegenxBio has a total of 492 patents globally, out of which 26 have been granted. Of these 492 patents, more than 85% patents are active. The United States of America is where RegenxBio has filed the maximum number of patents, followed by Canada and Australia. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of RegenxBio.

RegenxBio was founded in 2008. RegenxBio is a biotechnology business. The company’s primary areas of interest include recombine and adenoid-associated viral gene therapy development, marketing, and licensing.

Do read about some of the most popular patents of RegenxBio which have been covered by us in this article and also you can find RegenxBio patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over RegenxBio patent portfolio.

How many patents does RegenxBio have?

RegenxBio has a total of 492 patents globally. These patents belong to 71 unique patent families. Out of 492 patents, 423 patents are active.

How Many Patents did RegenxBio File Every Year?

RegenxBio Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantRegenxBio Applications FiledRegenxBio Patents Granted
2023183
20223813
20211295
2020105
2019722
2018592
2017311
201623
20153
201414

How many RegenxBio patents are Alive/Dead?

Worldwide Patents

RegenxBio Patent Portfolio

How Many Patents did RegenxBio File in Different Countries?

RegenxBio Worldwide Patent Filing

Countries in which RegenxBio Filed Patents

CountryPatent
United States Of America47
Canada44
Australia39
Europe38
Israel34
Hong Kong (S.A.R.)33
Korea (South)32
Singapore23
Japan23
Brazil21
Mexico20
Argentina18
Taiwan17
New Zealand7
Russia4
China4
Eurasia3
India3
South Africa2
Paraguay2
Uruguay2
Serbia1
Slovakia1
Bolivia1
Austria1
Colombia1
Denmark1
Lithuania1
Croatia1
Slovenia1
Poland1
Malta1
Portugal1
Hungary1
Malaysia1
Spain1
Norway1

Where are Research Centers of RegenxBio Patents Located?

R&D Centres of RegenxBio

10 Best RegenxBio Patents

WO2017136202A1 is the most popular patent in the RegenxBio portfolio. It has received 26 citations so far from companies like Voyager Therapeutics, Prevail Therapeutics, Ucl Business.

Below is the list of 10 most cited patents of RegenxBio:

Publication NumberCitation Count
WO2017136202A126
WO2019079494A123
US20210010025A119
WO2017181021A118
WO2019067540A115
US20180071373A114
WO2020033842A114
WO2019212922A113
WO2019212921A111
US20190038777A110

What are RegenxBio key innovation segments?

What Technologies are Covered by RegenxBio?

The chart below distributes patents filed by RegenxBio in different countries on the basis of the technology protected in patents. It also represents the markets where RegenxBio thinks it’s important to protect particular technology inventions.

R&D Focus: How has RegenxBio search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by RegenxBio?

Related Articles

Driveu Patents – Insights & Stats (Updated 2024)

Driveu has a total of 12 patents globally, out of which 8 have been granted. Of these 12 patents, more than 91% patents are active. Israel is where Driveu has filed the maximum number of patents, followed by United States of America and Europe (EPO). Parallelly, United States of America

Read More »

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.